Acceptability of midazolam and melatonin as premedications for anxious children undergoing general anaesthesia: a qualitative interview study with children, caregivers and health professionals participating in the MAGIC trial

Jennifer Kettle,Robert Bolt,Chris Deery,Diana Papaioannou,Helen Rodd,Marie C. Hyslop,Nikki Totton,Zoe Marshman
DOI: https://doi.org/10.1186/s13063-024-08611-x
IF: 2.728
2024-12-07
Trials
Abstract:The acceptability of a children's premedication, prior to general anaesthesia (GA), is fundamental to ensuring positive clinical- and patient-reported outcomes. Midazolam, the current standard premedication, is known to have an unfavourable side-effects profile and presents a degree of risk which is accepted due to a need for compliance. Melatonin is a functionally diverse hormone with anxiolytic properties that offer potential benefits over midazolam. Little is currently known about how patients and health professionals view these two different premedications. This research aimed to explore the acceptability of midazolam and melatonin as premedications for anxious children undergoing GA, from the perspective of children, caregivers and health professionals involved in the Melatonin for Anxiety prior to General Anaesthesia In Children (MAGIC) trial.
medicine, research & experimental
What problem does this paper attempt to address?